Inthera offered Human Immunoglobulin to action medeor to help the people of Ukraine.
Some decisions go beyond balance sheets. For a family-run business like Inthera, with over three decades spent navigating the pharmaceutical world, we know better than most that medicines are not just commercial products, they are lifelines. That belief has led us to take a step we are deeply proud of: donating a large package of human immunoglobulin to action medeor, the world's emergency pharmacy, for direct delivery to the population of Ukraine.
This donation represents action medeor's single largest gift-in-kind contribution so far in 2026, a fact that moves us, and that carries with it the full weight of responsibility we feel toward the people who will receive it.
Ukraine: A Healthcare System Under Siege
After more than four years of full-scale war, Ukraine's healthcare system is in a state of prolonged crisis. The numbers are stark. According to the World Health Organization, attacks on healthcare facilities in Ukraine increased by nearly 20% in 2025 compared to the previous year, the highest figure since the war began in February 2022. Since then, the WHO has documented at least 2,900 attacks on health infrastructure across the country, claiming the lives of over 230 health workers and patients, and injuring nearly 1,000 more.
Perhaps most alarming for the delivery of medicines: attacks on medical warehouses tripled in 2025, severing supply chains at their most critical points. When a warehouse is destroyed, the medicines inside it never reach the patients waiting for them.
The winter of 2025–2026 was described by WHO officials as the harshest since the conflict began. Repeated strikes on energy infrastructure left millions without heating, electricity, and clean water. In Kyiv alone, a single January 2026 attack left nearly 6,000 buildings without heat in subzero conditions. Medical facilities struggled to function. Patients already fighting serious illness were left without the stable, warm environments they needed to recover.
In frontline and hard-to-reach regions, access to essential medicines has become critically limited. Communities that once relied on functioning pharmacies and well-stocked hospitals now face month-long gaps in supply. For patients with chronic conditions, immune deficiencies, or acute medical needs, those gaps can be fatal.
What Is Human Immunoglobulin — and why does it matter?
Human immunoglobulin is not a drug people take when they have a cold. It is a life-sustaining therapy, derived from donated human blood plasma, used to treat patients with primary and secondary immune deficiencies and various serious conditios.
For these patients, immunoglobulin is not optional. Without immediate and regular infusions their health situation can become life-threatening. As one patient advocate put it simply: "Without immunoglobulin, we get sick. Our lives depend on it."
In a country at war, where hospital infrastructure has been damaged, supply chains disrupted, and healthcare workers stretched to their limits, ensuring that patients with immune deficiencies receive their therapy on schedule is an enormous challenge. Inthera's donation directly addresses that gap.
action medeor: the world's emergency pharmacy
For over 60 years, action medeor has been doing what governments and markets often cannot: getting life-saving medicines to people who need them most, in the places and at the moments they are needed. Founded in 1964 in Tönisvorst, Germany, the organisation has grown into one of the most respected medical aid organisations in the world.
In 2024 alone, action medeor sent 494 tons of medical supplies to 38 countries, reaching 10 million people directly and indirectly through its healthcare projects. Their approach is not simply transactional — they build distribution systems, train medical staff, equip health facilities, and provide long-term project support alongside their emergency response.
For Ukraine specifically, the scale of action medeor's commitment has been extraordinary. From the outbreak of the war in February 2022 to mid-2024, they dispatched more than 900 tons of medical supplies to hospitals across the country — medicines, surgical materials, bandages, syringes, oxygen concentrators, and more. They established distribution centres, delivered ambulances, and extended their reach into neighbouring Moldova to support Ukrainian refugee families.
Their guiding principle is simple and powerful: no one should suffer or die from a treatable or preventable disease. Inthera shares that belief unconditionally.
Inthera: putting expertise in service of people
Inthera is a family-owned pharmaceutical services company based in Budapest, Hungary, with over 33 years of experience in the industry. We specialise in clinical trial sourcing, medicine shortage supply, pharmaceutical regulatory affairs, and EU GMP services — working across 25 countries on three continents.
At the core of what we do is access. We have spent decades building the networks, the regulatory expertise, and the supplier relationships that allow us to source high-quality, EU-manufactured medicines reliably and efficiently. In a world where medicine shortages are increasingly common, that access carries a responsibility.
As a family business, we have always believed that responsibility extends beyond our clients and partners. It extends to the people at the end of the supply chain — the patients. When an opportunity arises to use what we have built in service of people who are suffering, there is, for us, only one possible response.
This donation is a reflection of that conviction.
A Donation with many purposes
The human immunoglobulin Inthera has donated will reach patients in Ukraine who are already fighting on multiple fronts: against illness, against disrupted supply chains, against the daily reality of a country at war. For those patients, receiving their therapy as scheduled is not a comfort — it is survival.
We are profoundly grateful to the team at action medeor for their tireless work, their integrity, and the trust they extend to partners like Inthera. And we are honoured that this donation will make a tangible difference to people who deserve so much more than the world has asked of them.
How you can help
If this story has moved you, we encourage you to learn more about action medeor's work and consider supporting them directly. Every donation, no matter the size, enables them to keep medicines flowing to the people who need them most.
Visit medeor.de/en to learn more about their mission, their work in Ukraine, and how you can contribute.
About Inthera
Inthera is a family-owned pharmaceutical services company with over 33 years of experience, headquartered in Budapest, Hungary. We specialise in clinical trial sourcing, medicine shortage supply, and regulatory affairs, serving clients across 25 countries on three continents. Learn more at inthera.net.
About action medeor
action medeor is a German medical aid organisation founded in 1964, known as the world's emergency pharmacy. They supply hospitals and health stations in crisis regions worldwide with medicines and medical equipment, and support long-term healthcare development. Learn more at medeor.de/en.